64
Views
1
CrossRef citations to date
0
Altmetric
Low Dimensional Solids and Molecular Crystals

Crystal and Molecular Structure Studies of a Novel 1-Benzhydryl-piperazine Derivative: 1-Benzhydryl-4-(4-chloro-2-fluoro-benzene-sulfonyl)-piperazine

, , , , , , & show all
Pages 151-158 | Published online: 03 Jun 2009
 

Abstract

The title compound 1-benzhydryl-4-(4-chloro-2-fluoro-benzenesulfonyl)-piperazine was synthesized, and structure of the product obtained was confirmed by the X-ray diffraction study. The compound C23H22ClFN2O2S crystallizes in the monoclinic crystal class in the space group P21/c with cell parameters a = 9.6180(7) Å , b = 12.9670(10) Å , c = 19.4020(12) Å , β = 114.716(3)°, and Z = 4. The structure has been solved by direct methods and refined to R 1 = 0.0440 for 3877 observed reflections with I > 2σ(I). The structure reveals that the piperazine ring is in a chair conformation. The geometry around the S atom is distorted tetrahedral.

ACKNOWLEDGMENTS

The authors are greatful to DST and Government of India for financial assistance under the projects SP/I2/FOO/93 and UGC-SAP(Phase-I)No.F.540/10/DRS/2004(SAP-I). One of the authors K. Vinaya, would like to thank CSIR, Government of India for the award of Senior Research Fellowship.

Notes

1“CCDC 705749 contains the supplementary crystallographic data for this article. These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from The Cambridge Crystal-lographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK. Fax: +44(0)1223-336033. E-mail: [email protected]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.